Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Reactivation of the Epstein-Barr virus from viral latency by an S-adenosylhomocysteine hydrolase/14-3-3 zeta/PLA2-dependent pathway.

Maas D, Maret C, Schaade L, Scheithauer S, Ritter K, Kleines M.

Med Microbiol Immunol. 2006 Dec;195(4):217-23. Epub 2006 Jun 21.

PMID:
16944201
2.

Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.

Gradoville L, Kwa D, El-Guindy A, Miller G.

J Virol. 2002 Jun;76(11):5612-26.

3.

TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein.

Murata T, Sato Y, Nakayama S, Kudoh A, Iwahori S, Isomura H, Tajima M, Hishiki T, Ohshima T, Hijikata M, Shimotohno K, Tsurumi T.

J Biol Chem. 2009 Mar 20;284(12):8033-41. doi: 10.1074/jbc.M808466200. Epub 2009 Jan 21.

4.
5.

The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.

Robinson AR, Kwek SS, Kenney SC.

PLoS Pathog. 2012 Feb;8(2):e1002516. doi: 10.1371/journal.ppat.1002516. Epub 2012 Feb 9.

6.
7.

PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter.

Lupey-Green LN, Moquin SA, Martin KA, McDevitt SM, Hulse M, Caruso LB, Pomerantz RT, Miranda JL, Tempera I.

Virology. 2017 Jul;507:220-230. doi: 10.1016/j.virol.2017.04.006. Epub 2017 Apr 26.

8.

Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.

Kraus RJ, Mirocha SJ, Stephany HM, Puchalski JR, Mertz JE.

J Virol. 2001 Jan;75(2):867-77.

9.
10.

Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.

Li L, Su X, Choi GC, Cao Y, Ambinder RF, Tao Q.

BMC Cancer. 2012 Mar 29;12:125. doi: 10.1186/1471-2407-12-125.

11.

Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.

Wille CK, Nawandar DM, Panfil AR, Ko MM, Hagemeier SR, Kenney SC.

J Virol. 2013 Jan;87(2):935-50. doi: 10.1128/JVI.01790-12. Epub 2012 Nov 7.

12.

Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.

Murata T, Narita Y, Sugimoto A, Kawashima D, Kanda T, Tsurumi T.

J Virol. 2013 Sep;87(18):10148-62. doi: 10.1128/JVI.01002-13. Epub 2013 Jul 10.

13.

The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.

Hergenhahn M, Soto U, Weninger A, Polack A, Hsu CH, Cheng AL, Rösl F.

Mol Carcinog. 2002 Mar;33(3):137-45.

PMID:
11870879
14.
15.

MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Jung YJ, Choi H, Kim H, Lee SK.

J Virol. 2014 Aug;88(16):9027-37. doi: 10.1128/JVI.00721-14. Epub 2014 Jun 4.

16.

Shutoff of BZLF1 gene expression is necessary for immortalization of primary B cells by Epstein-Barr virus.

Yu X, McCarthy PJ, Wang Z, Gorlen DA, Mertz JE.

J Virol. 2012 Aug;86(15):8086-96. doi: 10.1128/JVI.00234-12. Epub 2012 May 23.

17.

Herpes simplex virus type 1 infection activates the Epstein-Barr virus replicative cycle via a CREB-dependent mechanism.

Wu H, Li T, Zeng M, Peng T.

Cell Microbiol. 2012 Apr;14(4):546-59. doi: 10.1111/j.1462-5822.2011.01740.x. Epub 2012 Jan 18.

PMID:
22188237
18.

Histone acetylation and reactivation of Epstein-Barr virus from latency.

Jenkins PJ, Binné UK, Farrell PJ.

J Virol. 2000 Jan;74(2):710-20.

19.

Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.

Murata T, Kondo Y, Sugimoto A, Kawashima D, Saito S, Isomura H, Kanda T, Tsurumi T.

J Virol. 2012 May;86(9):4752-61. doi: 10.1128/JVI.06768-11. Epub 2012 Feb 22.

20.

Valpromide Inhibits Lytic Cycle Reactivation of Epstein-Barr Virus.

Gorres KL, Daigle D, Mohanram S, McInerney GE, Lyons DE, Miller G.

MBio. 2016 Mar 1;7(2):e00113. doi: 10.1128/mBio.00113-16.

Supplemental Content

Support Center